Pacira BioSciences, Inc.
PCRX· Nasdaq
Pacira BioSciences, Inc.
- Last sale
- Oct 1, 2026 · -0.08%
- Market cap
- $997.34M
- 39.86M shares
- Filings
- 1,017
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $726,411,000 | reported | |
| FY 2024 | 2024-12-31 | $700,966,000 | reported | |
| FY 2023 | 2023-12-31 | $674,978,000 | reported | |
| FY 2022 | 2022-12-31 | $666,823,000 | reported | |
| FY 2021 | 2021-12-31 | $538,966,000 | reported | |
| FY 2020 | 2020-12-31 | $426,614,000 | reported | |
| FY 2019 | 2019-12-31 | $418,926,000 | reported | |
| FY 2018 | 2018-12-31 | $332,427,000 | reported | |
| FY 2017 | 2017-12-31 | $286,630,000 | reported | |
| FY 2016 | 2016-12-31 | $276,371,000 | reported | |
| FY 2015 | 2015-12-31 | $248,997,000 | reported | |
| FY 2014 | 2014-12-31 | $197,668,000 | reported |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
